ArticleeNeurologicalSci2026
The role of hyperbaric oxygen therapy for treating spinal cord injury: Mechanisms, considerations, and research outcomes.
Article in eNeurologicalSci, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spinal cord injury (SCI) presents formidable challenges, with current regenerative treatments such as stem cell therapy and spinal stimulation showing inconsistent results in clinical trials. Advances in understanding the pathophysiology of SCI have directed regenerative strategies toward reducing inflammation and promoting angiogenesis. Hyperbaric oxygen therapy (HBOT), typically applied in pulmonary and dermatological contexts, emerges as a promising off-label treatment for SCI. This manuscript examines HBOT's mechanisms, clinical considerations, and outcomes in SCI, emphasizing its potential to enhance oxygenation, stimulate angiogenesis, reduce inflammation, and modify gene expression. Although further research is required to validate its efficacy fully, our analysis indicates that HBOT could significantly improve motor and sensory recovery in SCI patients, positioning it as a valuable therapeutic option.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.